ATXS vs SYF · rev $706.0K vs rev $11.19B
Astria Therapeutics Inc (ATXS) versus SYF (SYF) — a side-by-side from cached financials, not a winner call.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
SYF (SYF) common stock.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
Latest reported SYF revenue for 2026-06-30 was $11.19B. Net income was $1.69B. Revenue was up 99.6% from 2026-03-31 to 2026-06-30. SYF currently screens at market cap $0.
ATXS currently screens at market cap $382.1M. SYF currently screens at market cap $0.
Not investment advice. Open the ATXS and SYF stock pages for the full models.
Not investment advice.